1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,408 | 0,428 | 10:30 | |
| 0,410 | 0,426 | 09:56 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Fresh2 Group gets Nasdaq delinquency notice | 1 | Seeking Alpha | ||
| Mo | Fresh2 Group Ltd. Announces Receipt of a Delinquency Compliance Alert Notice from Nasdaq | 357 | GlobeNewswire (Europe) | New York, NY, April 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or the "Company"), a B2B e-commerce and supply chain management company within the restaurant and food... ► Artikel lesen | |
| Mo | Fresh2 Group Ltd - 8-K, Current Report | - | SEC Filings | ||
| 02.04. | Fresh2 Group Ltd - 8-K, Current Report | 2 | SEC Filings | ||
| 02.04. | Fresh2 Group Ltd - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 | 1 | SEC Filings | ||
| 25.03. | Fresh2 Group Ltd - 8-K, Current Report | 1 | SEC Filings | ||
| 20.02. | Fresh2 Group Ltd: Fresh2 Launches TikTok Video E-commerce Venture, Bridging the Gap Between Food Sources and Consumers | 2 | GlobeNewswire (USA) | ||
| 16.02. | Fresh2 Group Ltd - 8-K, Current Report | 1 | SEC Filings | ||
| 31.01. | Fresh2 Group announces receipt of Nasdaq deficiency notice | 2 | Seeking Alpha | ||
| 31.01. | Fresh2 Group Ltd. Announces Receipt of a Bid Deficiency Notice from Nasdaq | 125 | GlobeNewswire (Europe) | New York, NY, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ: FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry... ► Artikel lesen | |
| 29.01. | Fresh2 Group Ltd - 8-K, Current Report | 2 | SEC Filings | ||
| 04.01. | Fresh2 Acquires Youfood to Enhance Food Supply Chain Management Capabilities | 4 | PYMNTS.com | ||
| 04.01. | Fresh2 Group to acquire Youfood Group | 1 | Seeking Alpha | ||
| 15.12.23 | Fresh2 Group Ltd - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 04.12.23 | Fresh2 Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 09.11.23 | Fresh2 Group Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 19.05.23 | Fresh2 Group Limited: Fresh2 Group Ltd. Announces Nasdaq Ticker Symbol Change from 'ANPC' to 'FRES' | 532 | PR Newswire | Ticker symbol change effective at the market open May 22, 2023
NEW YORK, May 19, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ: ANPC), a company... ► Artikel lesen | |
| 16.05.23 | Fresh2 Group Limited: Fresh2 Reports Fiscal Year 2022 Annual Financial Results | 550 | PR Newswire | NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd.,"Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United... ► Artikel lesen | |
| 16.05.23 | Fresh2 Group Limited: Fresh2 Reports First Quarter of Fiscal Year 2023 Financial Results | 343 | PR Newswire | NEW YORK, May 16, 2023 /PRNewswire/ -- Fresh2 Group Limited (Formerly AnPac Bio-Medical Science Co., Ltd., "Fresh2," the "Company" or "we") (NASDAQ: ANPC), a company with operations in the United... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 12,714 | -0,95 % | Teladoc (TDOC) stock price analysis and the fall from grace | ||
| GERRESHEIMER | 100,10 | -1,28 % | JEFFERIES stuft GERRESHEIMER AG auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für Gerresheimer von 126 auf 128 Euro angehoben und die Einstufung auf "Buy" belassen. Es werde wohl noch ein Quartal dauern... ► Artikel lesen | |
| ROKU | 56,69 | -1,89 % | Qurate Launches 'The Big Dish' on The Roku Channel | ||
| BICO GROUP | 3,872 | +0,10 % | Bico Group Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
| PLUS THERAPEUTICS | 1,592 | +5,15 % | Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense | ||
| INVITAE | 0,110 | 0,00 % | Labcorp Wins Bid To Acquire Invitae Assets For $239 Mln Plus Non-Cash Considerations | WASHINGTON (dpa-AFX) - Invitae said that Labcorp (LH) has emerged as the successful bidder in the company's auction during its sale process under Section 363 of the U.S. Bankruptcy Code. Labcorp... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 1,446 | +2,70 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen | SEATTLE, April 09, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced promising safety and efficacy data from the Company's Phase 2 EVANGELINE... ► Artikel lesen | |
| MCKESSON | 499,00 | -0,28 % | McKesson declares $0.62 dividend | ||
| SONOMA PHARMACEUTICALS | 0,137 | +0,29 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Expansion of Negative-Pressure Wound Therapy Products for Use in the United States | BOULDER, CO / ACCESSWIRE / April 9, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,060 | -1,85 % | Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results | SALT LAKE CITY, March 14, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| CYTOSORBENTS | 0,788 | +2,07 % | CytoSorbents Reports Fourth Quarter and Full Year 2023 Results | STAR-T trial results selected for a Breakout Presentation at the American Association of Thoracic Surgery Annual Meeting in late-April 2024 CytoSorbents intends to submit DrugSorb-ATR for regulatory... ► Artikel lesen | |
| VOLITIONRX | 0,806 | 0,00 % | VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for Tuesday, March 26 at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., March 25, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE... ► Artikel lesen | |
| ONTRAK | 0,333 | +7,43 % | Delisting of Securities of Genesis Growth Tech Acquisition Corp.; Financial Strategies Acquisition Corp.; Kiromic BioPharma, Inc.; Infinity Pharmaceuticals, Inc.; Molekule Group, Inc.; EBET, Inc.; Shift Technologies, Inc.; Ontrak, Inc.; RVL Pharmaceutical | NEW YORK, Nov. 17, 2023 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market announced today that it will delist the securities of Genesis Growth Tech Acquisition Corp. Genesis Growth Tech Acquisition Corp.'s... ► Artikel lesen | |
| VERU | 1,199 | -3,15 % | LI, VERU and MRIN among pre-market losers |
FRESH2 GROUP LTD ADR gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 0,352 Euro und damit -14,56 % im Minus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
